Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
Royal Emerald Pharmaceuticals has raised $17.0M in total funding. The most recent round was Debt Financing. The last funding was announced in March 2022.
Royal Emerald Pharmaceuticals's investors include Pelorus Equity Group.
Royal Emerald Pharmaceuticals is headquartered in Desert Hot Springs, United States.
Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
Royal Emerald Pharmaceuticals is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Royal Emerald Pharmaceuticals — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/royal-emerald-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2022). Royal Emerald Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/royal-emerald-pharmaceuticals
{{cite web |title=Royal Emerald Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/royal-emerald-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated